<DOC>
	<DOCNO>NCT00470821</DOCNO>
	<brief_summary>Sleep disruption extremely common high-risk critically ill patient . The investigator want analyse oral melatonin potentiality sedative free-radicals scavenger critically ill patient , secondarily prevent Delirium ICU stay post-traumatic stress disorder ICU discharge .</brief_summary>
	<brief_title>Oral Melatonin Critically Ill High-risk Patients</brief_title>
	<detailed_description>The physiological secretion melatonin follow circadian rhythm : melatonin plasma concentration increase dark reach peak around midnight gradually decrease ( Reiter , 1996 ; Shigeta et al. , 2001 ; Kunz et al. , 2004 ; Brzezinski et al. , 2005 ) . Administration oral melatonin could useful critically ill high-risk patient Intensive Care Units patient often suffer sleep disturbance ( Weber et al. , 1985 ; Bourne Mills , 2004 ) possibly : - presence underlying pathology pain anxiety , - presence oral nasal respiratory prosthesis , - execution therapeutic procedure 24 h. Moreover demonstrate ICU patient melatonin rhythm desynchronize ( Bourne Mills , 2000 ) . This probably related sedation and-or mechanical ventilation . Furthermore , show melatonin powerful anti-oxidant , therefore could potentially useful critical patient usually characterize increased production oxygen free radical . AIM OF THE STUDY The study aim estimate administration oral melatonin ICU patient able regularize sleep-waking rhythm , improve sleep quality reduce episode agitation/mental confusion . The main objective : assessment sleep quality , prevalence mental confusion/agitation , amount daily sedative drug administer modification redox status . ENROLLMENT OF PATIENTS At admission ICU , obtain informed consent , patient randomly assign `` Treatment '' group receive melatonin 3mg BID oral route ( nasogastric tube ) `` Control '' group receive placebo . The sedation perform accord clinical standard . EXPERIMENTAL PROTOCOLS The following parameter monitor : - epidemiological data , - quality sleep estimate wrist actigraphy , - EEG profile 24h order estimate distribution sleep phase , - diurnal nocturnal hour sleep , - total amount sedative drug 24 hour , particularly nocturnal sedation , - assessment sedation level ( RASS ) ( Sessler et al. , 2002 ; Ely et al. , 2003 ) , - episode psychomotor agitation mental confusion ( CAM-ICU ) ( Ely , 2001 ; 2004 ) , - evaluation blood redox state ( GSH , GSSG , GSH/GSSG ) , - adverse event . AT THE DISCHARGE FROM ICU , evaluation : - SCID-I SCID-II ( Structured Clinical Interview DSM ) , - CAPS ( Clinician Administered PTSD Scales ) , - HAM-A HAM-D ( Hamilton Rating Scales Anxiety Depression ) , - completion module stressor ICU transcription dream . 3 MONTHS AFTER DISCHARGE FROM ICU , evaluation : - SCID-I II , - CAPS , - HAM-A HAM-D , - TAT ( Thematic Apperception Test ) , - completion module stressor ICU transcription dream .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>High Treatment &gt; 1 day Normal gastrointestinal function Status asthmaticus Chronic renal failure dialytic treatment Severe hepatopathy ( ChildPugh class = C ) Comatous patient ( GCS &lt; 12 ) Head trauma , severe neurological disease ( ictus cerebri , SAH , ... ) Intoxicated patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>melatonin</keyword>
	<keyword>actigraphy</keyword>
	<keyword>sedation</keyword>
	<keyword>critical patient</keyword>
	<keyword>ICU</keyword>
</DOC>